Post-Kidney Transplant Neutropenia After Alemtuzumab Induction: Risk Factors and Graft Outcomes.

被引：0
|
作者：
Zachariah, M. [1 ,2 ]
Fallahzadeh, M. [3 ]
Gumber, R. [1 ,2 ]
Kumar, A. [3 ]
Patel, S. [1 ,2 ]
Sharma, R. [1 ,2 ]
Singh, N. [3 ]
Gudleski, G. [1 ,2 ]
Venuto, R. [1 ,2 ]
机构：
[1] SUNY Buffalo, Dept Med, Buffalo, NY 14260 USA
[2] SUNY Buffalo, Dept Surg, Buffalo, NY 14260 USA
[3] LSUHSC Shreveport, Dept Internal Med, Shreveport, LA USA
来源：
TRANSPLANTATION | 2014年 / 98卷
关键词：
D O I：
10.1097/00007890-201407151-01962
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
C1805
引用
收藏
页码：582 / 582
页数：1
相关论文
共 50 条
  • [21] Frailty and Long-Term Post-Kidney Transplant Outcomes
    Mara A. McAdams-DeMarco
    Nadia M. Chu
    Dorry L. Segev
    Current Transplantation Reports, 2019, 6 : 45 - 51
  • [22] Delayed Graft Function in Living Donor Kidney Transplantation: Risk Factors and Outcomes.
    Defelice, G.
    Paramesh, A.
    Jeon, H.
    Atiemo, K.
    Killackey, M.
    Vijay, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 : 793 - 793
  • [23] Outcomes Using Alemtuzumab Induction in Pediatric Kidney Transplant Recipients
    Zhang Yifeng
    Kumar, Juhi
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 35 (10):
  • [24] Incidence, risk factors, and outcomes of post-transplant erythrocytosis after kidney transplantation
    Alzoubi, Beyann
    Kharel, Abish
    Osman, Fauzia
    Aziz, Fahad
    Garg, Neetika
    Mohamed, Maha
    Djamali, Arjang
    Mandelbrot, Didier A.
    Parajuli, Sandesh
    CLINICAL TRANSPLANTATION, 2021, 35 (02)
  • [25] Induction Immunotherapy in Elderly Kidney Transplant Recipients - Comparison between Alemtuzumab, Thymoglobulin and Basiliximab Induction Agents Long-Term Outcomes.
    Zachariah, M.
    Nader, N.
    Shah, S.
    Kandakurti, K.
    Venuto, R.
    Pankewycz, O.
    Laftavi, M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 315 - 315
  • [26] Post-Kidney Transplant Dementia Risk by Modifiable Risk Factors and CNIs Among Older Recipients.
    Chen, Y.
    Ahn, J.
    Chu, N.
    Bae, S.
    Schnitzler, M. A.
    Hess, G.
    Lentine, K.
    Segev, D.
    McAdams-DeMarco, M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 : 949 - 949
  • [27] Outcomes for High-Risk Post-Kidney Transplant Patients Admitted to the Intensive Care Unit
    Obizoba, I.
    Chao, N.
    Leon, B.
    Niederhaus, S.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2023, 23 (06) : S750 - S750
  • [28] Delayed Graft Function in Pediatric Kidney Transplant: Risk Factors and Outcomes
    Boussetta, Abir
    Abida, Nesrine
    Jellouli, Manel
    Ziadi, Jalel
    Gargah, Tahar
    EXPERIMENTAL AND CLINICAL TRANSPLANTATION, 2024, 22 (01) : 110 - 117
  • [29] Simultaneous Pancreas and Kidney Transplant Outcomes after Induction Therapy with Thymoglobulin Compared with Alemtuzumab.
    Masters, B.
    Bartlett, F.
    Drachenberg, C.
    Bartlett, S.
    Barth, R.
    Scalea, J.
    Haririan, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 488 - 489
  • [30] Alemtuzumab Induction and Post-Transplant Glomerulonephritis in Kidney Transplantation.
    Koutroutsos, K.
    Willicombe, M.
    Charif, R.
    Roufosse, C.
    Loucaidou, M.
    Cook, T.
    Taube, D.
    TRANSPLANTATION, 2014, 98 : 534 - 535
12345